ONCO-INNOVATIONS LTD (ONNVF:OTCMKTS)

$0.721 -0.1129 (-13.5388%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 59

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ONCO-INNOVATIONS LTD (ONNVF:OTCMKTS) News Sources

Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development

17-04-2026

yahoo.com

Onco-Innovations Announces Completion of Analytical Method Development for Monomer Intermediate 1 Supporting ONC010 Program

21-04-2026

yahoo.com

Onco-Innovations Advances Polymer Testing as It Moves Its PNKP Inhibitor Technology Toward IND-Enabling Studies

23-04-2026

yahoo.com

Onco-Innovations Announces Successful Scale-Up of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for its PNKP Inhibitor Technology Program

28-04-2026

yahoo.com

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies

01-05-2026

yahoo.com

Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation

05-05-2026

yahoo.com

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology

08-05-2026

yahoo.com

Onco-Innovations Announces Initiation of Research Collaboration within PROmAI

12-05-2026

yahoo.com

Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate

15-05-2026

yahoo.com

Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program

19-05-2026

yahoo.com

ONCO-INNOVATIONS LTD (ONNVF:OTCMKTS) Sentiment Trend

0 25 50 75 100 61 57 61 59 58 57 51 69 57 55 17-04-2026 21-04-2026 23-04-2026 28-04-2026 01-05-2026 05-05-2026 08-05-2026 12-05-2026 15-05-2026 19-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ONCO-INNOVATIONS LTD (ONNVF:OTCMKTS) FAQs

toggle

What is the current price of ONCO-INNOVATIONS LTD (ONNVF:OTCMKTS)?

The current price of ONCO-INNOVATIONS LTD (ONNVF:OTCMKTS) is $0.721.


toggle

ONCO-INNOVATIONS LTD (ONNVF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of ONCO-INNOVATIONS LTD (ONNVF:OTCMKTS) since the previous trading day is $-0.1129.


toggle

ONCO-INNOVATIONS LTD (ONNVF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of ONCO-INNOVATIONS LTD (ONNVF:OTCMKTS) since the previous trading day is -13.5388%.


toggle

What is the most recent average sentiment score for ONCO-INNOVATIONS LTD (ONNVF:OTCMKTS)?

The most recent average sentiment score for ONCO-INNOVATIONS LTD (ONNVF:OTCMKTS) is 59 out of 100.


toggle

What is the most recent average sentiment for ONCO-INNOVATIONS LTD (ONNVF:OTCMKTS)?

The most recent sentiment for ONCO-INNOVATIONS LTD (ONNVF:OTCMKTS) is .


SEC-8K** Filing Available For ONCO-INNOVATIONS LTD (ONNVF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.